118
Views
62
CrossRef citations to date
0
Altmetric
Original Article

Expression of B Cell Receptor-Associated Signaling Molecules in Human Lupus

, , &
Pages 213-224 | Received 14 Mar 2000, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Taher E. Taher, Hawzheen A. Muhammad, Edwige Bariller, Fabian Flores-Borja, Yves Renaudineau, David A. Isenberg & Rizgar A. Mageed. (2013) B-Lymphocyte Signalling Abnormalities and Lupus Immunopathology. International Reviews of Immunology 32:4, pages 428-444.
Read now
Frank J. Conrad, Jeffrey S. Rice & John C. Cambier. (2007) Multiple paths to loss of anergy and gain of autoimmunity. Autoimmunity 40:6, pages 418-424.
Read now

Articles from other publishers (60)

Shima Izadi, Sayed Reza Najfizadeh, Ahmad Nejati, Majid TeimooriRad, Shohreh Shahmahmoodi, Frough Golsaz Shirazi, Fazel Shokri & Sayed Mahdi Marashi. (2023) Potential role of EBV and Toll-like receptor 9 ligand in patients with systemic lupus erythematosus. Immunologic Research.
Crossref
Susana Minguet, Alexander Nyström, Dimitra Kiritsi & Marta Rizzi. (2022) Inborn errors of immunity and immunodeficiencies: Antibody‐mediated pathology and autoimmunity as a consequence of impaired immune reactions. European Journal of Immunology 52:9, pages 1396-1405.
Crossref
Andrew Getahun. (2022) Role of inhibitory signaling in peripheral B cell tolerance*. Immunological Reviews 307:1, pages 27-42.
Crossref
Yaxi Li, Hongting Wang, Zijing Zhang, Chenling Tang, Xinjin Zhou, Chandra Mohan & Tianfu Wu. (2022) Identification of polo‐like kinase 1 as a therapeutic target in murine lupus. Clinical & Translational Immunology 11:1.
Crossref
Sevgi Irtegun-Kandemir, Irmak Icen-Taskin, Mehtap Bozkurt & Sevgi Kalkanli-Tas. (2019) mRNA Expression Profile of SFKs and Involvement of SFKs in the Regulation of LPS-Induced Erk1/2 Signaling in PBMCs of Active BD Patients. Endocrine, Metabolic & Immune Disorders - Drug Targets 19:6, pages 809-817.
Crossref
S. Elizabeth Franks, Andrew Getahun & John C. Cambier. (2019) A Precision B Cell–Targeted Therapeutic Approach to Autoimmunity Caused by Phosphatidylinositol 3-Kinase Pathway Dysregulation. The Journal of Immunology 202:12, pages 3381-3393.
Crossref
S. Elizabeth Franks & John C. Cambier. (2018) Putting on the Brakes: Regulatory Kinases and Phosphatases Maintaining B Cell Anergy. Frontiers in Immunology 9.
Crossref
Xuexiao Jin, Shen Lu & Yang Yao. 2018. Stem Cells for Cancer and Genetic Disease Treatment. Stem Cells for Cancer and Genetic Disease Treatment 101 113 .
Susana Minguet, Kathrin Kläsener, Anna-Maria Schaffer, Gina J Fiala, Teresa Osteso-Ibánez, Katrin Raute, Inmaculada Navarro-Lérida, Frederike A Hartl, Maximilian Seidl, Michael Reth & Miguel A Del Pozo. (2017) Caveolin-1-dependent nanoscale organization of the BCR regulates B cell tolerance. Nature Immunology 18:10, pages 1150-1159.
Crossref
Chang Zeng, Cheng Fang, Hong Weng, Xiaoqing Xu, Tianyang Wu & Wenhua Li. (2017) B-cell lymphocyte kinase polymorphisms rs13277113, rs2736340, and rs4840568 and risk of autoimmune diseases. Medicine 96:36, pages e7855.
Crossref
S Iwata & Y Tanaka. (2016) B-cell subsets, signaling and their roles in secretion of autoantibodies. Lupus 25:8, pages 850-856.
Crossref
Andrew Getahun, Nicole A. Beavers, Sandy R. Larson, Mark J. Shlomchik & John C. Cambier. (2016) Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells. Journal of Experimental Medicine 213:5, pages 751-769.
Crossref
Thomas Dörner, Anthony Shock, David M. Goldenberg & Peter E. Lipsky. (2015) The mechanistic impact of CD22 engagement with epratuzumab on B cell function: Implications for the treatment of systemic lupus erythematosus. Autoimmunity Reviews 14:12, pages 1079-1086.
Crossref
Elias Hobeika, Peter J. Nielsen & David Medgyesi. (2015) Signaling mechanisms regulating B-lymphocyte activation and tolerance. Journal of Molecular Medicine 93:2, pages 143-158.
Crossref
Jieyue Liao, Christopher Chang, Haijing Wu & Qianjin Lu. (2015) Cell-based therapies for systemic lupus erythematosus. Autoimmunity Reviews 14:1, pages 43-48.
Crossref
Evelyn Tsantikos, Timothy A Gottschalk, Mhairi J Maxwell & Margaret L Hibbs. (2014) Role of the Lyn tyrosine kinase in the development of autoimmune disease. International Journal of Clinical Rheumatology 9:5, pages 519-535.
Crossref
Linda Åkerman, Johnny Ludvigsson & Rosaura Casas. (2013) Low C-peptide levels and decreased expression of TNF and CD45 in children with high risk of type 1 diabetes. Clinical Immunology 148:1, pages 4-15.
Crossref
Julie Zikherman, Ramya Parameswaran, Michelle Hermiston & Arthur Weiss. (2013) The Structural Wedge Domain of the Receptor-like Tyrosine Phosphatase CD45 Enforces B Cell Tolerance by Regulating Substrate Specificity. The Journal of Immunology 190:6, pages 2527-2535.
Crossref
Ram Raj Singh, Shweta Dubey & Julia Pinkhasov. 2013. Dubois' Lupus Erythematosus and Related Syndromes. Dubois' Lupus Erythematosus and Related Syndromes 256 272 .
Evelyn Tsantikos, Mhairi J. Maxwell, Nicole Kountouri, Kenneth W. Harder, David M. Tarlinton & Margaret L. Hibbs. (2012) Genetic Interdependence of Lyn and Negative Regulators of B Cell Receptor Signaling in Autoimmune Disease Development. The Journal of Immunology 189:4, pages 1726-1736.
Crossref
James C. Paulson, Matthew S. Macauley & Norihito Kawasaki. (2012) Siglecs as sensors of self in innate and adaptive immune responses. Annals of the New York Academy of Sciences 1253:1, pages 37-48.
Crossref
Gitit Shahaf, Andrew J. Gross, Michal Sternberg‐Simon, Deborah Kaplan, Anthony L. DeFranco & Ramit Mehr. (2011) Lyn deficiency affects B‐cell maturation as well as survival. European Journal of Immunology 42:2, pages 511-521.
Crossref
Evan Ingley. (2012) Functions of the Lyn tyrosine kinase in health and disease. Cell Communication and Signaling 10:1, pages 21.
Crossref
Allison Sang, Yiming Yin, Ying-Yi Zheng & Laurence Morel. 2012. Animal Models of Molecular Pathology. Animal Models of Molecular Pathology 321 370 .
Ye Fan, Jin-Hui Tao, Li-Ping Zhang, Lian-Hong Li & Dong-Qing Ye. (2010) Association of BLK (rs13277113, rs2248932) polymorphism with systemic lupus erythematosus: a meta-analysis. Molecular Biology Reports 38:7, pages 4445-4453.
Crossref
Sébastien Lemoine, Ahsen Morva, Pierre Youinou & Christophe Jamin. (2011) Human T cells induce their own regulation through activation of B cells. Journal of Autoimmunity 36:3-4, pages 228-238.
Crossref
Anne-Sophie Korganow, Anne-Marie Knapp, Hélène Nehme-Schuster, Pauline Soulas-Sprauel, Vincent Poindron, Jean-Louis Pasquali & Thierry Martin. (2010) Peripheral B cell abnormalities in patients with systemic lupus erythematosus in quiescent phase: Decreased memory B cells and membrane CD19 expression. Journal of Autoimmunity 34:4, pages 426-434.
Crossref
Scott A. Jenks & Iñaki Sanz. (2009) Altered B cell receptor signaling in human systemic lupus erythematosus. Autoimmunity Reviews 8:3, pages 209-213.
Crossref
A Hostmann, AM Jacobi, H Mei, F Hiepe & T Dörner. (2008) Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus. Lupus 17:12, pages 1064-1069.
Crossref
Torkel VangAna V. MileticYutaka ArimuraLutz TautzRobert C. RickertTomas Mustelin. (2008) Protein Tyrosine Phosphatases in Autoimmunity. Annual Review of Immunology 26:1, pages 29-55.
Crossref
Sergey V Kozyrev, Anna-Karin Abelson, Jerome Wojcik, Ammar Zaghlool, M V Prasad Linga Reddy, Elena Sanchez, Iva Gunnarsson, Elisabet Svenungsson, Gunnar Sturfelt, Andreas Jönsen, Lennart Truedsson, Bernardo A Pons-Estel, Torsten Witte, Sandra D'Alfonso, Nadia Barizzone, Maria Giovanna Danieli, Carmen Gutierrez, Ana Suarez, Peter Junker, Helle Laustrup, Maria Francisca González-Escribano, Javier Martin, Hadi Abderrahim & Marta E Alarcón-Riquelme. (2008) Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nature Genetics 40:2, pages 211-216.
Crossref
Moncef Zouali. 2008. National Institute of Allergy and Infectious Diseases, NIH. National Institute of Allergy and Infectious Diseases, NIH 377 384 .
Yutaka Nakiri, Kentarou Minowa, Jun Suzuki, Akiko Mitsuo, Hirofumi Amano, Shinji Morimoto, Yoshiaki Tokano & Yoshinari Takasaki. (2007) Expression of CD22 on peripheral B cells in patients with rheumatoid arthritis: relation to CD5-positive B cells. Clinical Rheumatology 26:10, pages 1721-1723.
Crossref
Pierre Youinou. (2007) B cell conducts the lymphocyte orchestra. Journal of Autoimmunity 28:2-3, pages 143-151.
Crossref
Fabian Flores-Borja, Panagiotis S. Kabouridis, Elizabeth C. Jury, David A. Isenberg & Rizgar A. Mageed. (2007) Altered lipid raft–associated proximal signaling and translocation of CD45 tyrosine phosphatase in B lymphocytes from patients with systemic lupus erythematosus. Arthritis & Rheumatism 56:1, pages 291-302.
Crossref
Zhe Liu, Ritu Dawes, Svetla Petrova, Peter CL Beverley & Elma Z Tchilian. (2006) CD45 regulates apoptosis in peripheral T lymphocytes. International Immunology 18:6, pages 959-966.
Crossref
Stamatis‐Nick C. Liossis, Elena E. Solomou & Petros P. Sikakis. (2006) Lyn deficiency in B cells from patients with systemic lupus erythematosus: Comment on the article by Flores‐Borja et al. Arthritis & Rheumatism 54:6, pages 2036-2037.
Crossref
Fabian Flores‐Borja, Panagiotis S. Kabouridis, Elizabeth C. Jury, David A. Isenberg & Rizgar A. Mageed. (2006) Reply. Arthritis & Rheumatism 54:6, pages 2037-2038.
Crossref
Fabian Flores-Borja, Panagiotis S. Kabouridis, Elizabeth C. Jury, David A. Isenberg & Rizgar A. Mageed. (2005) Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus. Arthritis & Rheumatism 52:12, pages 3955-3965.
Crossref
Andrew J. Gross, Donna Hochberg, William M. Rand & David A. Thorley-Lawson. (2005) EBV and Systemic Lupus Erythematosus: A New Perspective. The Journal of Immunology 174:11, pages 6599-6607.
Crossref
PIERRE YOUINOU, CHRISTOPHE JAMIN, JACQUES-OLIVIER PERS, CHRISTIAN BERTHOU, ALAIN SARAUX & YVES RENAUDINEAU. (2005) B Lymphocytes Are Required for Development and Treatment of Autoimmune Diseases. Annals of the New York Academy of Sciences 1050:1, pages 19-33.
Crossref
Christine M. Grimaldi, Ruthmarie Hicks & Betty Diamond. (2005) B Cell Selection and Susceptibility to Autoimmunity. The Journal of Immunology 174:4, pages 1775-1781.
Crossref
Yuekang Xu, Kenneth W. Harder, Nicholas D. Huntington, Margaret L. Hibbs & David M. Tarlinton. (2005) Lyn Tyrosine Kinase. Immunity 22:1, pages 9-18.
Crossref
Moncef Zouali. 2005. Molecular Autoimmunity. Molecular Autoimmunity 227 243 .
Moncef Zouali & Gabriella Sarmay. (2004) B lymphocyte signaling pathways in systemic autoimmunity: Implications for pathogenesis and treatment. Arthritis & Rheumatism 50:9, pages 2730-2741.
Crossref
Noriko Asano, Manabu Fujimoto, Norihito Yazawa, Senji Shirasawa, Minoru Hasegawa, Hitoshi Okochi, Kunihiko Tamaki, Thomas F. Tedder & Shinichi Sato. (2004) B Lymphocyte Signaling Established by the CD19/CD22 Loop Regulates Autoimmunity in the Tight-Skin Mouse. The American Journal of Pathology 165:2, pages 641-650.
Crossref
T DörnerP E Lipsky. (2016) Correlation of circulating CD27high plasma cells and disease activity in systemic lupus erythematosus. Lupus 13:5, pages 283-289.
Crossref
P J Utz. (2016) Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus. Lupus 13:5, pages 304-311.
Crossref
Junji Otsuka, Takahiko Horiuchi, Shigeru Yoshizawa, Hiroshi Tsukamoto, Takuya Sawabe, Yuji Kikuchi, Daisuke Himeji, Takako Koyama, Hiroki Mitoma, Takeshi Watanabe & Mine Harada. (2004) Association of a four–amino acid residue insertion polymorphism of the HS1 gene with systemic lupus erythematosus: Molecular and functional analysis. Arthritis & Rheumatism 50:3, pages 871-881.
Crossref
Elena Peeva & Betty Diamond. 2004. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus 283 314 .
George C. Tsokos. 2004. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus 29 92 .
S. Bedoui, R. Pabst & S. von Hörsten. 2004. Neuropeptide Y and Related Peptides. Neuropeptide Y and Related Peptides 409 445 .
Annett M. Jacobi, Marcus Odendahl, Karin Reiter, Anne Bruns, Gerd R. Burmester, Andreas Radbruch, Günter Valet, Peter E. Lipsky & Thomas Dörner. (2003) Correlation between circulating CD27 high plasma cells and disease activity in patients with systemic lupus erythematosus . Arthritis & Rheumatism 48:5, pages 1332-1342.
Crossref
Michelle L. HermistonZheng XuArthur Weiss. (2003) CD45: A Critical Regulator of Signaling Thresholds in Immune Cells. Annual Review of Immunology 21:1, pages 107-137.
Crossref
Nicholas R. Pritchard & Kenneth G. C. Smith. (2003) B cell inhibitory receptors and autoimmunity. Immunology 108:3, pages 263-273.
Crossref
Cheng Zhou, Andrew Saxon & Ke Zhang. (2003) Human Activation-Induced Cytidine Deaminase Is Induced by IL-4 and Negatively Regulated by CD45: Implication of CD45 as a Janus Kinase Phosphatase in Antibody Diversification. The Journal of Immunology 170:4, pages 1887-1893.
Crossref
Amrie C. Grammer & Peter E. Lipsky. (2002) CD154-CD40 interactions mediate differentiation to plasma cells in healthy individuals and persons with systemic lupus erythematosus. Arthritis & Rheumatism 46:6, pages 1417-1429.
Crossref
J P Mitchell, E J Enyedy, M P Nambiar, A Lees & G C Tsokos. (2016) Engagement of complement receptor 2 on the surface of B cells from patients with systemic lupus erythematosus contributes to the increased responsiveness to antigen stimulation. Lupus 11:5, pages 299-303.
Crossref
Moncef Zouali. (2002) B cell diversity and longevity in systemic autoimmunity. Molecular Immunology 38:12-13, pages 895-901.
Crossref
Paul Hasler & Moncef Zouali. (2001) B cell receptor signaling and autoimmunity. The FASEB Journal 15:12, pages 2085-2098.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.